Aprea Therapeutics Inc (APRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Operating Expenses | 52,811 | 29,544 | 16,489 | 15,852 | 0 |
| Operating Income | -52,811 | -29,544 | -16,489 | -15,852 | N/A |
| Other Income | -668 | 1,485 | 961 | 662 | 0 |
| Pre-tax Income | -53,479 | -28,060 | -15,528 | -15,190 | 0 |
| Net Income Continuous | -53,479 | -28,060 | -15,528 | -15,190 | N/A |
| Net Income | $-53,479 | $-28,060 | $-15,528 | $-15,190 | $N/A |
| EPS Basic Total Ops | -50.61 | -93.40 | -269.00 | -263.40 | N/A |
| EPS Basic Continuous Ops | -50.59 | -93.50 | -269.12 | -263.49 | N/A |
| EPS Diluted Total Ops | -50.61 | -93.40 | -269.00 | -263.40 | N/A |
| EPS Diluted Continuous Ops | -50.59 | -93.50 | -269.12 | -263.49 | N/A |
| EPS Diluted Before Non-Recurring Items | -50.60 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-52,582 | $-29,374 | $-16,481 | $-15,844 | $N/A |